Orthopediatrics (NASDAQ: KIDS) — Perfil da empresa, notícias e dados financeiros
Orthopediatrics specializes in orthopedic products for children, delivering innovative solutions for pediatric trauma and deformities.
Orthopediatrics
Orthopediatrics (NASDAQ:KIDS) specializes in developing orthopedic products and solutions exclusively designed for children. This unique focus addresses the distinct challenges in pediatric orthopedics and promotes better surgical outcomes for younger patients. Their diverse product portfolio includes innovative medical devices for trauma and deformities, scoliosis, and sports medicine, engineered to meet the growing needs of pediatric orthopedic surgery. With a strong commitment to improving the lives of children around the world, Orthopediatrics aims to expand its reach and enhance its product offerings through ongoing research and strategic partnerships. The company's primary objective is to be at the forefront of pediatric orthopedic care, ensuring surgeons have the specialized tools needed to care for young patients effectively.
Resumo
Operações
Produtos e/ou serviços de Orthopediatrics
- Pediatric orthopedic implants for trauma and deformity corrections, specializing in technology tailored for growing bodies.
- Surgical navigation systems designed to enhance precision in pediatric orthopedic surgeries.
- Custom implants and instruments for rare and complex pediatric orthopedic conditions, providing personalized solutions.
- A comprehensive line of spinal hardware designed specifically for pediatric patients, including solutions for scoliosis.
- Clubfoot solutions including braces and bar systems, supporting non-invasive treatments in infants and young children.
- Educational programs and resources for healthcare professionals on the latest advancements in pediatric orthopedic care.
equipe executiva do Orthopediatrics
- Mark C. ThrodahlExecutive Chairman
- David R. BaileyPresident, CEO & Director
- Fred L. HiteCFO, Principal Financial & Accounting Officer, COO and Director
- Daniel J. GerritzenExecutive VP of Legal, General Counsel & Secretary
- Gregory A. OdlePresident of Scoliosis
- Joseph W. HauserPresident of Trauma, Deformity Correction & OPSB
- Kevin L. UngerPresident of Enabling Technologies
- Mark KarshnerSenior Vice President of International Sales
- Ray GarrisonSenior Vice President of Quality & Regulatory and Clinical
Últimas notícias sobre a Orthopediatrics
Principais indicadores financeiros
Resultados divulgados pela Orthopediatrics , em USD.
- Cap. de mercado
- 811,1 mi
- Receita (TTM)
- 252,7 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.4
- Dividend yield
- —
- Margem de lucro
- -12.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 236,3 mi | -29 mi | -39,6 mi | |
| 204,7 mi | -29,5 mi | -37,8 mi | |
| 148,7 mi | -26,8 mi | -21 mi | |
| 122,3 mi | -25,4 mi | 1,3 mi |